OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials
Syed Nasir Abbas Bukhari
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 866-866
Open Access | Times Cited: 46
Syed Nasir Abbas Bukhari
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 866-866
Open Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges
Francisco Rodríguez, Pablo Caruana, Noa De la Fuente, et al.
Biomolecules (2022) Vol. 12, Iss. 6, pp. 784-784
Open Access | Times Cited: 142
Francisco Rodríguez, Pablo Caruana, Noa De la Fuente, et al.
Biomolecules (2022) Vol. 12, Iss. 6, pp. 784-784
Open Access | Times Cited: 142
Nanoparticle-mediated cancer cell therapy: basic science to clinical applications
Jaya Verma, Caaisha Warsame, Rajkumar Kottayasamy Seenivasagam, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 601-627
Open Access | Times Cited: 54
Jaya Verma, Caaisha Warsame, Rajkumar Kottayasamy Seenivasagam, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 601-627
Open Access | Times Cited: 54
Nanotherapeutic approaches for delivery of long non-coding RNAs: an updated review with emphasis on cancer
Fatemeh Davodabadi, Shekoufeh Mirinejad, Sumira Malik, et al.
Nanoscale (2024) Vol. 16, Iss. 8, pp. 3881-3914
Closed Access | Times Cited: 10
Fatemeh Davodabadi, Shekoufeh Mirinejad, Sumira Malik, et al.
Nanoscale (2024) Vol. 16, Iss. 8, pp. 3881-3914
Closed Access | Times Cited: 10
Advances in erlotinib delivery systems: Addressing challenges and exploring opportunities in EGFR-targeted cancer therapies
Mehrab Pourmadadi, Vahideh Mohammadzadeh, Zahra Mohammadi, et al.
Inorganic Chemistry Communications (2024) Vol. 161, pp. 112114-112114
Closed Access | Times Cited: 9
Mehrab Pourmadadi, Vahideh Mohammadzadeh, Zahra Mohammadi, et al.
Inorganic Chemistry Communications (2024) Vol. 161, pp. 112114-112114
Closed Access | Times Cited: 9
Nanoscale strides: exploring innovative therapies for breast cancer treatment
Sruthi Laakshmi Mugundhan, M. Mothilal
RSC Advances (2024) Vol. 14, Iss. 20, pp. 14017-14040
Open Access | Times Cited: 8
Sruthi Laakshmi Mugundhan, M. Mothilal
RSC Advances (2024) Vol. 14, Iss. 20, pp. 14017-14040
Open Access | Times Cited: 8
Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology
Gong Zhang, Junhui Hou, Chenxue Mei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114260-114260
Open Access | Times Cited: 16
Gong Zhang, Junhui Hou, Chenxue Mei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114260-114260
Open Access | Times Cited: 16
A Review of the Efficacy of Nanomaterial-Based Natural Photosensitizers to Overcome Multidrug Resistance in Cancer
Jagadeesh Rajaram, Lokesh Kumar Mende, Yaswanth Kuthati
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1120-1120
Open Access | Times Cited: 5
Jagadeesh Rajaram, Lokesh Kumar Mende, Yaswanth Kuthati
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1120-1120
Open Access | Times Cited: 5
Advancing Cancer Drug Delivery with Nanoparticles: Challenges and Prospects in Mathematical Modeling for In Vivo and In Vitro Systems
Tozivepi Aaron Munyayi, Anine Crous
Cancers (2025) Vol. 17, Iss. 2, pp. 198-198
Open Access
Tozivepi Aaron Munyayi, Anine Crous
Cancers (2025) Vol. 17, Iss. 2, pp. 198-198
Open Access
Recent advancements in nanoparticles for cancer treatment
Dinesh Kumar Sharma
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access
Dinesh Kumar Sharma
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access
An overview of nanotherapeutics and nanodiagnostics
Shashi Ravi Suman Rudrangi, H. Basavaraj, Ashok Pawar, et al.
Elsevier eBooks (2025), pp. 19-40
Closed Access
Shashi Ravi Suman Rudrangi, H. Basavaraj, Ashok Pawar, et al.
Elsevier eBooks (2025), pp. 19-40
Closed Access
Non-coding RNAs: emerging biomarkers and therapeutic targets in cancer and inflammatory diseases
Basma Hossam Abdelmonem, Lereen T. Kamal, Lilian Waheed Wardy, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Basma Hossam Abdelmonem, Lereen T. Kamal, Lilian Waheed Wardy, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
A review of nanomaterials from synthetic and natural molecules for prospective breast cancer nanotherapy
Pankaj Kumar, Bharti Mangla, Shamama Javed, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11
Pankaj Kumar, Bharti Mangla, Shamama Javed, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11
Liposomes for Cancer Theranostics
Donald A. Fernandes
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2448-2448
Open Access | Times Cited: 11
Donald A. Fernandes
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2448-2448
Open Access | Times Cited: 11
Drug Resistance: The Role of Exosomal miRNA in the Microenvironment of Hematopoietic Tumors
Mariaconcetta Cariello, Angela Squilla, Martina Piacente, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 116-116
Open Access | Times Cited: 15
Mariaconcetta Cariello, Angela Squilla, Martina Piacente, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 116-116
Open Access | Times Cited: 15
Recent Advances in the Development of Nanodelivery Systems Targeting the TRAIL Death Receptor Pathway
Anne V. Yagolovich, Marine E. Gasparian, Д. А. Долгих
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 515-515
Open Access | Times Cited: 8
Anne V. Yagolovich, Marine E. Gasparian, Д. А. Долгих
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 515-515
Open Access | Times Cited: 8
A biomimetic adipocyte mesenchymal stem cell membrane-encapsulated drug delivery system for the treatment of rheumatoid arthritis
Chaoyu Gu, Shaoying Yang, Xuesong Liu, et al.
Nano Research (2023) Vol. 16, Iss. 8, pp. 11401-11410
Closed Access | Times Cited: 8
Chaoyu Gu, Shaoying Yang, Xuesong Liu, et al.
Nano Research (2023) Vol. 16, Iss. 8, pp. 11401-11410
Closed Access | Times Cited: 8
Harnessing Machine Learning Potential for Personalised Drug Design and Overcoming Drug Resistance
Mohammed Ageeli Hakami
Journal of drug targeting (2024) Vol. 32, Iss. 8, pp. 918-930
Closed Access | Times Cited: 2
Mohammed Ageeli Hakami
Journal of drug targeting (2024) Vol. 32, Iss. 8, pp. 918-930
Closed Access | Times Cited: 2
Current Trends and Advances in Nanoplatforms-Based Imaging for Cancer Diagnosis
Kovuri Umadevi, Dola Sundeep, Alluru Raghavendra Vighnesh, et al.
Indian Journal of Microbiology (2024)
Closed Access | Times Cited: 2
Kovuri Umadevi, Dola Sundeep, Alluru Raghavendra Vighnesh, et al.
Indian Journal of Microbiology (2024)
Closed Access | Times Cited: 2
Recent advances in stimuli-responsive nano-heterojunctions for tumor therapy
Jing Ping, Jun Du, Ruizhuo Ouyang, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 226, pp. 113303-113303
Closed Access | Times Cited: 7
Jing Ping, Jun Du, Ruizhuo Ouyang, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 226, pp. 113303-113303
Closed Access | Times Cited: 7
TiO2 Nanoparticles in Cancer Therapy as Nanocarriers in Paclitaxel’s Delivery and Nanosensitizers in Phototherapies and/or Sonodynamic Therapy
Fernanda Maria Policarpo Tonelli, Flávia C.P. Tonelli, Helon Guimarães Cordeiro
Current Pharmaceutical Biotechnology (2023) Vol. 25, Iss. 2, pp. 133-143
Closed Access | Times Cited: 5
Fernanda Maria Policarpo Tonelli, Flávia C.P. Tonelli, Helon Guimarães Cordeiro
Current Pharmaceutical Biotechnology (2023) Vol. 25, Iss. 2, pp. 133-143
Closed Access | Times Cited: 5
Revolutionizing Cancer Treatment: Biopolymer‐Based Aerogels as Smart Platforms for Targeted Drug Delivery
Hala M. Alkhalidi, Amerh Aiad Alahmadi, Waleed Y. Rizg, et al.
Macromolecular Rapid Communications (2024) Vol. 45, Iss. 9
Closed Access | Times Cited: 1
Hala M. Alkhalidi, Amerh Aiad Alahmadi, Waleed Y. Rizg, et al.
Macromolecular Rapid Communications (2024) Vol. 45, Iss. 9
Closed Access | Times Cited: 1
Cancer nanotechnology: a new approach to upgrade cancer diagnosis and therapy
Dorsa Morshedi Rad, Hojjatollah Nazari, Vahid Yaghoubi Naei, et al.
Elsevier eBooks (2024), pp. 37-62
Closed Access | Times Cited: 1
Dorsa Morshedi Rad, Hojjatollah Nazari, Vahid Yaghoubi Naei, et al.
Elsevier eBooks (2024), pp. 37-62
Closed Access | Times Cited: 1
Copper sulfide-based hollow nanoarchitectonics for augmented photothermal, chemodynamic, and chemotherapeutic modalities
Mingjia Yu, Ruo-Yin Meng, Hong‐Ying Xia, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 97, pp. 105768-105768
Closed Access | Times Cited: 1
Mingjia Yu, Ruo-Yin Meng, Hong‐Ying Xia, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 97, pp. 105768-105768
Closed Access | Times Cited: 1
Application of a Novel Nanotherapeutic Strategy in Ayurvedic Treatment
Sumanta Bhattacharya
Lecture notes in nanoscale science and technology (2024), pp. 199-228
Closed Access | Times Cited: 1
Sumanta Bhattacharya
Lecture notes in nanoscale science and technology (2024), pp. 199-228
Closed Access | Times Cited: 1
An eco friendly approach for the development of a dipeptide based anti-TB drug nanocomposites: A greener approach in drug delivery system for pulmonary delivery
Usharani Nagarajan, Monica Denise R, Swarna V. Kanth, et al.
Sustainable materials and technologies (2024) Vol. 41, pp. e01037-e01037
Closed Access | Times Cited: 1
Usharani Nagarajan, Monica Denise R, Swarna V. Kanth, et al.
Sustainable materials and technologies (2024) Vol. 41, pp. e01037-e01037
Closed Access | Times Cited: 1
